Skip to main content
. 2018 Apr 17;27(7):781–788. doi: 10.1002/pds.4440

Figure 3.

Figure 3

Influence of drug exposure data preparation assumptions on association between oral hypoglycaemic drug class (sulfonylureas compared with biguanides as referent) and CVD events: Effect of changing one data preparation option from primary pathway